PFS
TGTX icon

Prospera Financial Services’s TG Therapeutics TGTX Stock Holding History

Prospera Financial Services’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$694K Sell
12,625
-8,373
-40% -$343K 0.01% 911
2026
Q1 		$698K Sell
20,998
-5,495
-21% -$164K 0.01% 871
2025
Q4 		$790K Sell
26,493
-4,230
-14% -$138K 0.01% 770
2025
Q3 		$1.11M Buy
30,723
+648
+2% +$21.3K 0.02% 643
2025
Q2 		$1.08M Buy
30,075
+1,112
+4% +$41.4K 0.02% 626
2025
Q1 		$1.14M Sell
28,963
-5,550
-16% -$187K 0.03% 528
2024
Q4 		$1.04M Sell
34,513
-1,200
-3% -$34.4K 0.02% 531
2024
Q3 		$835K Sell
35,713
-2,712
-7% -$59.2K 0.02% 551
2024
Q2 		$684K Sell
38,425
-665
-2% -$10.6K 0.02% 604
2024
Q1 		$595K Buy
39,090
+750
+2% +$11.9K 0.02% 649
2023
Q4 		$655K Buy
38,340
+6,865
+22% +$79.8K 0.02% 574
2023
Q3 		$263K Buy
31,475
+200
+0.6% +$2.79K 0.01% 852
2023
Q2 		$777K Sell
31,275
-6,000
-16% -$155K 0.03% 485
2023
Q1 		$561K Buy
37,275
+18,625
+100% +$283K 0.02% 577
2022
Q4 		$221K Buy
+18,650
New +$135K 0.01% 816
2022
Q3 		– Sell
-6,700
Closed -$28K – 1518
2022
Q2 		$28K Sell
6,700
-620
-8% -$3.87K ﹤0.01% 1142
2022
Q1 		$70K Buy
+7,320
New +$84.7K ﹤0.01% 1237

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Prospera Financial Services's TGTX Position: Q2 2026 in Review

Prospera Financial Services reduced its TG Therapeutics (TGTX) stake by 40% in Q2 2026, selling an estimated $343K and leaving 12,625 shares worth $694K. The position accounts for 0.01% of the portfolio, ranked #911.

Prospera Financial Services first reported a position in TGTX in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.14M in Q1 2025. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Prospera Financial Services held 12,625 shares of TG Therapeutics worth $694K as of Q2 2026.
  • Prospera Financial Services sold 8,373 TG Therapeutics shares in Q2 2026, an estimated $343K.
  • TG Therapeutics made up 0.01% of Prospera Financial Services's portfolio in Q2 2026, its #911 holding.
  • Prospera Financial Services first reported a position in TG Therapeutics in Q1 2022 and has held it in 17 quarters since.
  • Prospera Financial Services's TG Therapeutics position peaked at $1.14M in Q1 2025.
  • 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.